The Extracellular Matrix Metalloproteinase Inducer (EMMPRIN, CD147) - a potential novel target in atherothrombosis prevention?

Nader Joghetaei, Andreas Stein, Robert A. Byrne, Christian Schulz, Lamin King, Andreas E. May, Roland Schmidt*

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review

22 Citations (Scopus)

Abstract

The immunoglobulin superfamily member EMMPRIN (CD147) plays an important role in a number of organ systems, including the cardiovascular system. Here we review the contemporary understanding of EMMPRIN and EMMPRIN- associated sequelae in the course of atherosclerosis. A significant body of data documents the pivotal role of EMMPRIN in the complex processes of atherogenesis, atheroprogression, and acute atherosclerothrombosis, a role that goes beyond that of a mere marker of inflammation. (C) 2013 Elsevier Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)474-480
Number of pages7
JournalThrombosis Research
Volume131
Issue number6
DOIs
Publication statusPublished - Jun 2013

Keywords

  • Atherogenesis
  • Atherothrombosis
  • EMMPRIN
  • LOW-DENSITY LIPOPROTEINS
  • SMOOTH-MUSCLE-CELLS
  • IMMUNOGLOBULIN SUPERFAMILY
  • FOAM CELLS
  • MYOCARDIAL-INFARCTION
  • MONOCLONAL-ANTIBODIES
  • LIGAND CYCLOPHILIN
  • EXPRESSION
  • ATHEROSCLEROSIS
  • COLLAGENASE

Fingerprint

Dive into the research topics of 'The Extracellular Matrix Metalloproteinase Inducer (EMMPRIN, CD147) - a potential novel target in atherothrombosis prevention?'. Together they form a unique fingerprint.

Cite this